Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Recruiting 6Completed 6Active not recruiting 6Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 2Thoracic 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroendocrine Tumors 1Kidney Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Advanced Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 66Cyclophosphamide 44Cisplatin 43Nivolumab 36Paclitaxel 32Carboplatin 31Radiotherapy 29Gemcitabine 28Docetaxel 25Dexamethasone 22atezolizumab 21Doxorubicin 19Bevacizumab 19Magnetic Resonance Spectroscopy 17fludarabine 16Vincristine 16Lenalidomide 16Etoposide 16Radiosurgery 15Letrozole 15Ipilimumab 15Fluorouracil 15Blood Specimen Collection 15palbociclib 14Rituximab 14Radiation 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13Specimen Handling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Axitinib × 90 days × Clear all
NCT05017012 2026-06-05

MK-3475A-C18

Merck Sharp & Dohme LLC

Phase 1 Completed
142 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT05420220 2026-05-28

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 2 Completed
95 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT01334073 2026-05-14

EVAX

University Hospital, Bordeaux

Phase 1 Completed
19 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02535533 2026-05-06

SLM + Axitinib for Clear Cell RCC

University of Iowa

Phase 1/2 Completed
45 enrolled 18 charts
Genitourinary

Kidney Neoplasms

NCT01744249 2026-04-28

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Grupo Espanol de Tumores Neuroendocrinos

Phase 2/3 Completed
256 enrolled 25 charts
EndocrineNET

Neuroendocrine Tumors

NCT04355156 2026-04-16

AXMUS-C

Imperial College London

Phase 2 Completed
52 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡